FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.3124
-0.0277 (-8.14%)
At close: Mar 13, 2026, 4:00 PM EDT
0.3175
+0.0051 (1.63%)
After-hours: Mar 13, 2026, 7:56 PM EDT
FibroBiologics Employees
FibroBiologics had 15 employees as of December 31, 2025. The number of employees increased by 2 or 15.38% compared to the previous year.
Employees
15
Change (1Y)
2
Growth (1Y)
15.38%
Revenue / Employee
n/a
Profits / Employee
-$1,243,067
Market Cap
21.12M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 15 | 2 | 15.38% |
| Dec 31, 2024 | 13 | 3 | 30.00% |
| Dec 31, 2023 | 10 | 3 | 42.86% |
| Sep 30, 2023 | 8 | 1 | 14.29% |
| Jun 30, 2023 | 7 | - | - |
| Dec 31, 2022 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Barinthus Biotherapeutics | 105 |
| Boundless Bio | 64 |
| Vistagen Therapeutics | 59 |
| Daré Bioscience | 23 |
| Skye Bioscience | 16 |
| Neuphoria Therapeutics | 8 |
| Allarity Therapeutics | 7 |
| NanoViricides | 7 |
FBLG News
- 2 days ago - FibroBiologics Announces Advances in Burn Treatment Using Proprietary Fibroblast Spheroid Technology - GlobeNewsWire
- 9 days ago - FibroBiologics Completes Site Onboarding for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers - GlobeNewsWire
- 12 days ago - FibroBiologics, Inc. Announces Issuance of U.S. Patent Covering Fibroblast Cell Therapy for the Treatment of Osteoporosis - GlobeNewsWire
- 16 days ago - FibroBiologics to Present at the BIO Investment & Growth Summit - GlobeNewsWire
- 18 days ago - FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 19 days ago - FibroBiologics Granted Extension by Nasdaq to Regain Compliance - GlobeNewsWire
- 4 weeks ago - FibroBiologics' Chairman & CEO Pete O'Heeron Selected to Present at A4LI's H-SPAN Summit at Georgetown University - GlobeNewsWire
- 5 weeks ago - FibroBiologics Announces Issuance of Canadian Patent Covering Novel Fibroblast-Based Treatment for Cachexia - GlobeNewsWire